Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD

Published:2019-07-09 Issue:4 Volume:70 Page:1424-1436
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Rinella Mary E.¹,Tacke Frank²^ORCID,Sanyal Arun J.³,Anstee Quentin M.⁴,

Affiliation:

1. Department of Gastroenterology Northwestern University Feinberg School of Medicine Chicago IL

2. Department of Hepatology/Gastroenterology Charité University Medical Center Berlin Germany

3. Department of Internal Medicine Virginia Commonwealth University Richmond VA

4. Institute of Cellular Medicine Newcastle University Newcastle Upon Tyne United Kingdom

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30782

Reference46 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

4. Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis;Journal of Gastroenterology and Hepatology;2024-08-16

2. Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease;Alimentary Pharmacology & Therapeutics;2024-08-08

3. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?;Metabolism;2024-08

4. A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease;Diabetes & Metabolism Journal;2024-07-31

5. Application and research progress of magnetic resonance proton density fat fraction in metabolic dysfunction-associated steatotic liver disease: a comprehensive review;Abdominal Radiology;2024-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3